Evidence map›Paper›PMID 33543589›Full record

ArticleAddiction biology2021

Translating preclinical models of alcohol seeking and consumption into the human laboratory using intravenous alcohol self-administration paradigms.

Melissa A Cyders, Martin H Plawecki, Zachary T Whitt, Ann E K Kosobud, David A Kareken, Ulrich S Zimmermann, Sean J O'Connor

Abstract read
In one paragraph

Article in Addiction biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Aversion-resistant alcohol seeking in the human laboratory.Alcohol, clinical & experimental research · 2025
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Melissa A CydersDepartment of Psychology, Indiana University-Purdue University, Indianapolis, Indiana, USA.ORCID 0000-0003-1990-8337
Martin H PlaweckiDepartment of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Zachary T WhittDepartment of Psychology, Indiana University-Purdue University, Indianapolis, Indiana, USA.
Ann E K KosobudDepartment of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
David A KarekenDepartment of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Ulrich S ZimmermannSchool of Medicine, Technische Universität Dresden, Dresden, Germany.
Sean J O'ConnorDepartment of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Funding

Translational Research and Science Education (OUT)P60AA007611 · NIAAA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI DAVID A. KAREKEN · 2003 to 2026
$45.5M
RAT RESEARCH COMPONENTP50AA007611 · NIAAA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI BOSRON, WILLIAM F · 1987 to 2002
$5.3M
Sex Differences in the Response to Abstinence from Alcohol.R01AA027236 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI CYDERS, MELISSA A, PLAWECKI, MARTIN H. · 2018 to 2022
$2.9M
Brain reward responses to sweet tastes in alcoholism riskR01AA022476 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI KAREKEN, DAVID A. · 2014 to 2018
$2.8M
Collaboration on Alcohol Self-Administration in Adolescents and Young AdultsU01AA017900 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI O'CONNOR, SEAN JOSEPH · 2009 to 2012
$1.1M
NIAAA NIH HHS P50 AA007611NIAAA NIH HHS P60 AA007611NIAAA NIH HHS R01 AA022476NIAAA NIH HHS R01 AA027236NIAAA NIH HHS U01 AA017900
6 · The paper itself

Abstract

Preclinical models of alcohol use disorder (AUD) have advanced theoretical, mechanistic, and pharmacological study of the human condition. "Liking" and "wanting" behaviors reflect core processes underlying several models of AUD. However, the development and application of translational models of these preclinical approaches are at an incipient stage. The goal of this study was to examine how intravenous free-access and progressive-ratio, operant-response human alcohol self-administration paradigms can be used as translational human model parallels of preclinical "liking" and "wanting." Participants were 40 adults (mean age = 23.7, SD = 2.0; 45% female) of European descent who reported 12.6 drinking days (SD = 5.2) out of the previous 30 (average = 4.1 drinks per drinking day [SD = 1.7]). Individuals diverged in their alcohol self-administration behavior, such that free-access and progressive-ratio paradigm outcomes were not significantly correlated (p = 0.44). Free-access alcohol seeking was related to enjoying alcohol (p < 0.001), but not craving (p = 0.48), whereas progressive-ratio seeking at similar levels of alcohol exposure was related to craving (p = 0.02), but not enjoying (p = 0.30). Family history of alcoholism, venturesomeness traits, and disinhibition traits were unrelated (ps > 0.70) to preferred level of breath alcohol concentration (BrAC) in the free-access session, a measure of liking alcohol. Family history of alcoholism, disinhibition traits, and recent drinking history were significantly related (ps < 0.05) to alcohol seeking in the progressive-ratio paradigm, a measure of wanting alcohol. We conclude that intravenous alcohol self-administration paradigms show promise in modeling behaviors that characterize and parallel alcohol "liking" and "wanting" in preclinical models. These paradigms provide a translational link between preclinical methods and clinical trials.

Indexed as

Drug-Seeking BehaviorAdultAlcohol DrinkingAlcoholismBlood Alcohol ContentCravingFemaleHumansMaleMedical History TakingMotivationSelf AdministrationSex FactorsYoung AdultBlood Alcohol Contentaddictionalcohol use disorderhuman laboratoryintravenous alcohol self-administration

Identifiers

PMID33543589
PMCPMC8339186

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.